444 related articles for article (PubMed ID: 26686042)
1. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
[TBL] [Abstract][Full Text] [Related]
2. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
3. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
[TBL] [Abstract][Full Text] [Related]
4. Understanding financial toxicity in head and neck cancer survivors.
Mady LJ; Lyu L; Owoc MS; Peddada SD; Thomas TH; Sabik LM; Johnson JT; Nilsen ML
Oral Oncol; 2019 Aug; 95():187-193. PubMed ID: 31345389
[TBL] [Abstract][Full Text] [Related]
5. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
McLean L; Hong W; McLachlan SA
Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
[TBL] [Abstract][Full Text] [Related]
6. Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003.
Banthin JS; Bernard DM
JAMA; 2006 Dec; 296(22):2712-9. PubMed ID: 17164457
[TBL] [Abstract][Full Text] [Related]
7. Does public insurance provide better financial protection against rising health care costs for families of children with special health care needs?
Yu H; Dick AW; Szilagyi PG
Med Care; 2008 Oct; 46(10):1064-70. PubMed ID: 18815528
[TBL] [Abstract][Full Text] [Related]
8. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.
Zafar SY; Peppercorn JM; Schrag D; Taylor DH; Goetzinger AM; Zhong X; Abernethy AP
Oncologist; 2013; 18(4):381-90. PubMed ID: 23442307
[TBL] [Abstract][Full Text] [Related]
9. Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer.
Honda K; Gyawali B; Ando M; Kumanishi R; Kato K; Sugiyama K; Mitani S; Masuishi T; Narita Y; Bando H; Taniguchi H; Kadowaki S; Ura T; Muro K
J Glob Oncol; 2019 May; 5():1-8. PubMed ID: 31070981
[TBL] [Abstract][Full Text] [Related]
10. Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study.
Offodile AC; Asaad M; Boukovalas S; Bailey C; Lin YL; Teshome M; Greenup RA; Butler C
Ann Surg Oncol; 2021 May; 28(5):2451-2462. PubMed ID: 33051742
[TBL] [Abstract][Full Text] [Related]
11. Financial toxicity and its associated patient and cancer factors among women with breast cancer: a single-center analysis of low-middle income region in China.
Jing J; Feng R; Zhang X; Li M; Gao J
Breast Cancer Res Treat; 2020 Jun; 181(2):435-443. PubMed ID: 32306169
[TBL] [Abstract][Full Text] [Related]
12. The Personal Financial Burden Associated with Musculoskeletal Trauma.
Bhashyam AR; McGovern MM; Mueller T; Heng M; Harris MB; Weaver MJ
J Bone Joint Surg Am; 2019 Jul; 101(14):1245-1252. PubMed ID: 31318803
[TBL] [Abstract][Full Text] [Related]
13. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors.
Kale HP; Carroll NV
Cancer; 2016 Apr; 122(8):283-9. PubMed ID: 26991528
[TBL] [Abstract][Full Text] [Related]
14. A national cross-sectional survey of financial toxicity among bladder cancer patients.
Ehlers M; Bjurlin M; Gore J; Pruthi R; Narang G; Tan R; Nielsen M; Zhu A; Deal A; Smith A
Urol Oncol; 2021 Jan; 39(1):76.e1-76.e7. PubMed ID: 33268274
[TBL] [Abstract][Full Text] [Related]
15. Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.
Bailey CM; Asaad M; Boukovalas S; Lin YL; Kothamasu V; Kapur SK; Villa MT; Butler CE; Offodile AC
Plast Reconstr Surg; 2021 Jul; 148(1):1e-11e. PubMed ID: 34181599
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
Beeler WH; Bellile EL; Casper KA; Jaworski E; Burger NJ; Malloy KM; Spector ME; Shuman AG; Rosko A; Stucken CL; Chinn SB; Dragovic AF; Chapman CH; Owen D; Jolly S; Bradford CR; Prince MEP; Worden FP; Jagsi R; Mierzwa ML; Swiecicki PL
Oral Oncol; 2020 Feb; 101():104521. PubMed ID: 31877502
[TBL] [Abstract][Full Text] [Related]
17. Crowdsourcing to measure financial toxicity in gynecologic oncology.
Esselen KM; Stack-Dunnbier H; Gompers A; Hacker MR
Gynecol Oncol; 2021 May; 161(2):595-600. PubMed ID: 33551197
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis.
Shankaran V; Jolly S; Blough D; Ramsey SD
J Clin Oncol; 2012 May; 30(14):1608-14. PubMed ID: 22412136
[TBL] [Abstract][Full Text] [Related]
19. Personal financial effects of multiple myeloma and its treatment.
Goodwin JA; Coleman EA; Sullivan E; Easley R; McNatt PK; Chowdhury N; Stewart CB
Cancer Nurs; 2013; 36(4):301-8. PubMed ID: 23047800
[TBL] [Abstract][Full Text] [Related]
20. Surgical follow-up costs disproportionately impact low-income patients.
Scott AR; Rush AJ; Naik AD; Berger DH; Suliburk JW
J Surg Res; 2015 Nov; 199(1):32-8. PubMed ID: 26013443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
